Ilaria Casetti
5PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.Nicole S Arellano, William L Heaton, Mirielle C Nauman
|Dec 23, 2022
COVID-19 in Patients with Hematologic Diseases.Ilaria Carola Casetti, Oscar Borsani, Elisa Rumi
|Nov 10, 2022
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand
|Apr 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.Juan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz
|Jan 31, 2022
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.Oscar Borsani, Paul Bastard, Jérémie Rosain
Pageof 1
Frequent Collaborators
5 joint publications
Elisa Rumi
4 joint publications
Daniela Pietra
3 joint publications
Oscar Borsani
2 joint publications
Silvia Catricalà
2 joint publications
Caroline Marty
2 joint publications
Shannon E Elf
2 joint publications
Isabelle Plo
2 joint publications
Nicole S Arellano
2 joint publications
Michele Ciboddo
1 joint publications
Stefan N Constantinescu
